4564.T OncoTherapy Science JPX pre-market 05 Feb 2026: Q4 results and key catalysts
In pre-market trade on 05 Feb 2026, 4564.T stock is steady at JPY 20.00 as investors parse the company’s recent earnings timing and clinical updates. The biotech’s market cap is JPY 6,872,871,920.00 and average daily volume sits near 51,384,668.00 shares. Trailing EPS is -2.83 and PE reads -7.07, underscoring continued negative earnings. We focus on how clinical milestones and the latest results could shift valuation for JPX-listed OncoTherapy Science, Inc.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →